Matters Capital’s Eli Lilly LLY Stock Holding History

Matters Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Hold	2,374	–	–	1.99%	17
2026 Q1	$2.18M	Hold	2,374	–	–	1.94%	18
2025 Q4	$2.55M	Buy	+2,374	New	+$2.27M	2.09%	16

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Matters Capital's LLY Position: Q2 2026 in Review

Matters Capital held its Eli Lilly (LLY) position steady in Q2 2026 at 2,374 shares worth $2.85M. The position accounts for 1.99% of the portfolio, ranked #17.

Matters Capital first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Matters Capital held 2,374 shares of Eli Lilly worth $2.85M as of Q2 2026.
Matters Capital left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 1.99% of Matters Capital's portfolio in Q2 2026, its #17 holding.
Matters Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Matters Capital's 13F filing for Q2 2026, filed 12 Aug 2026.